Skip to main content
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriatic Arthritis
1
1
Biologic Therapy
0
0.91
Arthritis
0
0.87
Spondylitis, Spondylosis, Kyphosis
0
0.41
Child
0
0.39
Hospital
0
0.19
Anti-Tumor Necrosis Factor (Anti-TNF)
0
0.14
Axial spondyloarthritis
0
0.11
Europe
0
0.1
Grant
0
0.1
Interleukin
0
0.1
Tumor
0
0.1
Specialty
Lead
score
Rheumatology
1
1
Dermatology
0
0.9
Pediatrics
0
0.8
Pharmacist
0
0.7
Edit Tags